(Reuters Health) - - The medicine in emergency allergy shots like the EpiPen can deteriorate when exposed to heat, so don't leave them in the car on a hot day, researchers warn.
Shares of Tivity Health Inc plummeted over 30 percent on Monday after the company's deal to buy diet plan developer Nutrisystem Inc in a bid to strike new partnerships with large health insurers was met with skepticism.
WILMINGTON, Del Akorn Inc said late on Friday its Chief Executive Officer would retire following the drugmaker's inability to salvage its takeover deal with Germany's Fresenius SE .
Mallinckrodt Plc plans to spin off its specialty generics business to shareholders by the second half of 2019, but said it was still open to a sale of the unit.
(Reuters Health) - Most primary care physicians in the U.S. are willing to provide routine care to transgender individuals, but that doesn't mean they are well prepared to do so, a small study suggests.
- Acupuncture and yoga could offer relief from the hot flashes of menopause, a new analysis suggests.
Eight medical device makers, including a startup that uses virtual reality to treat chronic pain, topped an innovation contest aimed at addressing the opioid crisis, the U.S. Food and Drug Administration said on Friday.
The U.S. Food and Drug Administration on Wednesday approved a blood cancer treatment from Japan's Astellas Pharma Inc, making it the first targeted therapy to treat patients with a certain mutation.
(Reuters Health) - Vendors at farmers' markets could benefit from lessons in food-safety, according to researchers at Pennsylvania State University.
The health science arm of Nestle SA will pay $98 million to raise its stake in Aimmune Therapeutics Inc, the drug developer said, as it prepares to submit a marketing application for its peanut allergy drug by the end of the year.